A top vaccine official at the U.S. Food and Drug Administration (FDA) is stepping down, warning that vaccine misinformation is coloring the country’s top health decisions. Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said he will resign and retire by April 5. In a letter to the acting FDA… read on > read on >
Experts say move could negatively impact oral health, especially among children and low-income communities read on >
As a measles outbreak spreads across the United States, doctors are now seeing a new and unexpected danger: Children getting sick from taking too much vitamin A. At Covenant Children’s Hospital in Lubbock, Texas, several unvaccinated children showed signs of liver problems after taking large amounts of vitamin A, according to Dr. Lara Johnson, the… read on > read on >
Splenda doesn’t directly add calories to your diet, but the sweetener still might lead people to pack on pounds, a new study says. The sugar substitute might spur on a person’s appetite and feelings of hunger, potentially leading them to overeat, according to results published March 26 in the journal Nature Metabolism. Splenda’s main ingredient,… read on > read on >
A mom’s health and lifestyle choices can affect her kids’ risk of obesity as adults, a new study says. Specifically, a child is 3 to 4 times more likely to become an obese adult if their mom was obese, researchers reported March 26 in PLOS One. A mom’s smoking also increased their kid’s risk of… read on > read on >
Artificial intelligence (AI) can help improve how premature babies are fed, giving them a better chance at normal growth and development, a new study says. Currently, preemies in a neonatal intensive care unit are fed by IV, receiving a drip-drop handmade blend of nutrients that doctors call total parenteral nutrition, or TPN. This is the… read on > read on >
Medication approved for uUTIs in women and pediatric patients aged 12 years and older read on >
Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity and diabetes drug, the company announced March 24. The drug, called UBT251, is being developed by United Bio-Technology (Hengqin) Co., a Chinese pharmaceutical company. Novo Nordisk will pay $200 million up front,… read on > read on >
Statins are very cheap and highly effective cholesterol-lowering drugs — but high-risk heart patients may have an even better option, a new evidence review says. Combining statins with another drug, ezetimibe, significantly reduces the risk of death in patients with clogged arteries, according to findings published March 23 in Mayo Clinic Proceedings. Using a high-dose… read on > read on >
Lifestyle factors like diet, exercise, smoking and blood pressure have a greater impact on the heart health of women than men, a new study says. Women with poor health have nearly five times the risk of heart disease compared to women with ideal health, according to findings scheduled for presentation Saturday at a meeting of… read on > read on >
